Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324362 · ClinicalTrials.gov registry record · Phase 4
GSK BHR Study (Sont - Second Study)
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 446
- Enrollment target
NCT01324362: Completed Phase 4 study, sponsored by GlaxoSmithKline.
NCT01324362 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 446 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (14% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01324362, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 446 participants
- Enrollment target
Study Summary
The purpose of this study was to determine whether asthma control and reduced bronchial responsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS BID or FP BID in adult and adolescent patients with persistent asthma
Interventions
- DRUG Placebo
- DRUG FP 100mcg
- DRUG FP 500mcg
- DRUG FP 250mcg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2003-01 |
| Est. Completion | 2004-10 |
| Phase | Phase 4 |
What the finished NCT01324362 record still lists
NCT01324362 is an interventional study that assigns participants to a tested intervention. The registered 446 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (14% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01324362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01324362 about?
NCT01324362 is a clinical study titled "GSK BHR Study (Sont - Second Study)". The purpose of this study was to determine whether asthma control and reduced bronchial responsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS BID or FP BID in adult and adolescent patients with persistent asthma
What is the current status of trial NCT01324362?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 446 participants. The study started on 2003-01. Estimated completion is 2004-10.
What interventions are being tested in trial NCT01324362?
The interventions under investigation include: Placebo (DRUG), FP 100mcg (DRUG), FP 500mcg (DRUG), FP 250mcg (DRUG).
Who is sponsoring clinical trial NCT01324362?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01324362's enrollment target sits among peer trials
446 189th of 2000 higher than 1,811 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia